Olga A. Sharshova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olga A. Sharshova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr Aleksandrovich Bezmenko
Kirov Military Medical Academy
4 shared publications - Igor S. Zakharov
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation
4 shared publications - Alina A. Nazarenko
S.M. Kirov Military Medical Academy
3 shared publications - Anatoly R. Sharshov
St Petersburg University
2 shared publications - Mikhail G. Karailanov
Military Medical Academy
2 shared publications - Veronica I. Malyugina
S. M. Kirov Military Medical Academy
2 shared publications
Latest Publications
- 17 May 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (3)
Telemedicine — the history of development and current state
In 2025, it will be 120 years since the first successful full-fledged telemedicine communication. This article describes the main stages of telemedicine development. The first attempts to provide remote medical care are inextricably linked with the invention of the telegraph. Throughout the 20th century and the first quarter of the 21st century, telemedicine technologies have been progressively developing. The authors analyzed the general chronological dynamics of the distribution of scientific publications on telemedicine — a significant increase in publication activity occurred during the COVID-19 pandemic, which became an important stage in the development and transformation of this area of medical services. Using cluster analysis, a classification of areas in which telemedicine is actively used was carried out. Promising areas were identified, one of which is the combination of telemedicine with artificial intelligence. The active development of telemedicine is changing approaches to medical care and forming a new understanding of the relationship «doctor–patient», «doctor–doctor» and «patient–patient».
- 17 May 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (3)
Telemedicine — the history of development and current state
In 2025, it will be 120 years since the first successful full-fledged telemedicine communication. This article describes the main stages of telemedicine development. The first attempts to provide remote medical care are inextricably linked with the invention of the telegraph. Throughout the 20th century and the first quarter of the 21st century, telemedicine technologies have been progressively developing. The authors analyzed the general chronological dynamics of the distribution of scientific publications on telemedicine — a significant increase in publication activity occurred during the COVID-19 pandemic, which became an important stage in the development and transformation of this area of medical services. Using cluster analysis, a classification of areas in which telemedicine is actively used was carried out. Promising areas were identified, one of which is the combination of telemedicine with artificial intelligence. The active development of telemedicine is changing approaches to medical care and forming a new understanding of the relationship «doctor–patient», «doctor–doctor» and «patient–patient».
- 30 April 2026
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
- Vol. 34 (4) , 44-53
Assessing the Level of Acceptance of Artificial Intelligence in Colposcopy: Results of a Cross-Sectional Survey of Obstetricians and Gynecologists
Introduction: Despite the active adoption of digital innovations in healthcare delivery, the acceptance of artificial intelligence in the medical community remains unclear. Objective: To establish AI acceptance in colposcopy by surveying obstetricians and gynecologists. Materials and Methods: We conducted a cross-sectional anonymous survey of 392 obstetricians and gynecologists in St. Petersburg and the Leningrad Region. The developed questionnaire included three sets of questions: the first set characterized the respondent’s profile; the second set comprised questions related to the Unified Theory of Acceptance and Use of Technology; and the third set of additional questions addressed the risks of adopting new technologies, including ethical and legal aspects. Results and Discussion: We observed positive trends in obstetricians and gynecologists’ intentions to use artificial intelligence in their practice. At the same time, the analysis revealed a number of problems, including insufficient trust in AI-generated results, limited availability of equipment and technical support. Another issue of concern for healthcare professionals is the partial substitution of their functions. Furthermore, the majority of respondents (247 (63 %)) believe that the existing legal framework is insufficient for the safe practical AI use. Moreover, many respondents (292 (74.5 %)) believe that legal liability for artificial intelligence errors should lie with the healthcare facility and the software developer, while only one in five respondents (80 (20.4 %)) believes that liability should be shared. Conclusions: This study is the first to provide a comprehensive assessment of the readiness of obstetricians and gynecologists to use artificial intelligence tools in colposcopy in the Russian Federation. It should be assumed that the level of hypothetical support for the adoption of innovations may be quite high but practical implementation is limited by infrastructural barriers and legal uncertainty.
- 30 April 2026
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
- Vol. 34 (4) , 44-53
Assessing the Level of Acceptance of Artificial Intelligence in Colposcopy: Results of a Cross-Sectional Survey of Obstetricians and Gynecologists
Introduction: Despite the active adoption of digital innovations in healthcare delivery, the acceptance of artificial intelligence in the medical community remains unclear. Objective: To establish AI acceptance in colposcopy by surveying obstetricians and gynecologists. Materials and Methods: We conducted a cross-sectional anonymous survey of 392 obstetricians and gynecologists in St. Petersburg and the Leningrad Region. The developed questionnaire included three sets of questions: the first set characterized the respondent’s profile; the second set comprised questions related to the Unified Theory of Acceptance and Use of Technology; and the third set of additional questions addressed the risks of adopting new technologies, including ethical and legal aspects. Results and Discussion: We observed positive trends in obstetricians and gynecologists’ intentions to use artificial intelligence in their practice. At the same time, the analysis revealed a number of problems, including insufficient trust in AI-generated results, limited availability of equipment and technical support. Another issue of concern for healthcare professionals is the partial substitution of their functions. Furthermore, the majority of respondents (247 (63 %)) believe that the existing legal framework is insufficient for the safe practical AI use. Moreover, many respondents (292 (74.5 %)) believe that legal liability for artificial intelligence errors should lie with the healthcare facility and the software developer, while only one in five respondents (80 (20.4 %)) believes that liability should be shared. Conclusions: This study is the first to provide a comprehensive assessment of the readiness of obstetricians and gynecologists to use artificial intelligence tools in colposcopy in the Russian Federation. It should be assumed that the level of hypothetical support for the adoption of innovations may be quite high but practical implementation is limited by infrastructural barriers and legal uncertainty.
- 1 January 2026
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 14 (1)
Use of artificial intelligence in obstetrics and gynecology – from origins to current trends
- 1 January 2026
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 14 (1)
Use of artificial intelligence in obstetrics and gynecology – from origins to current trends
- Open Access
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 95-102
IMPACT OF AUTOIMMUNE DISEASES ON CERVICAL INTRAEPITHELIAL NEOPLASIA RISK
The article presents an analysis of scientific studies investigating the effect of autoimmune diseases (AIDs) on the risk of developing cervical intraepithelial lesions, including cervical cancer. 458 scientific publications in foreign and domestic search engines PubMed, Cochrane, and Elibrary were analyzed by keywords and their combinations: "cervical cancer", "autoimmune diseases", "immunosuppressive therapy", "cervical intraepithelial neoplasia", "risk of developing cervical cancer". The final review included 28 articles. The qualitative analysis allowed us to form an idea of the effect of AIDs on the development of intraepithelial neoplastic changes in cervical cancer (CC), in the pathogenesis of which an important place is occupied by the chronic inflammatory process – there is activation of signaling pathways, including NF-kB, JAK-STAT, MAPK and TLR. These agents induce the production of various proinflammatory, tissue-damaging factors, such as cytokines, chemokines, and metalloproteinases. In addition, both in AID and in CC, activated inflammasomes and the signaling pathway of the GMP-AMP interferon synthase stimulating gene (cGAS-STING) are involved in the development of chronic inflammation. It is noted that the C5aR system is associated with carcinogenesis activity and the recruitment of myeloid suppressor cells MDSC, which suppress the antitumor immune response. The presence of immunosuppressive therapy (mainly the use of azathioprine) plays an important role in the progression of intraepithelial changes in the cervix. Several studies present data on the positive effect of vaccination against human papillomavirus (HPV) in patients with systemic lupus erythematosus, while it is recommended to vaccinate against HPV regardless of the presence or absence of this virus in anamnesis. Along with the literature review, the article presents a clinical case of intraepithelial cervical lesion in a patient with systemic lupus erythematosus. Therefore, immunological changes in AIDs in combination with immunosuppressive therapy can contribute to the progression of carcinogenesis. At the same time, it should be noted that when studying this topic, controversial issues remain, which require further development of this problem.
- 1 January 2025
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 37 (3) , 95-102
Open AccessIMPACT OF AUTOIMMUNE DISEASES ON CERVICAL INTRAEPITHELIAL NEOPLASIA RISK
The article presents an analysis of scientific studies investigating the effect of autoimmune diseases (AIDs) on the risk of developing cervical intraepithelial lesions, including cervical cancer. 458 scientific publications in foreign and domestic search engines PubMed, Cochrane, and Elibrary were analyzed by keywords and their combinations: "cervical cancer", "autoimmune diseases", "immunosuppressive therapy", "cervical intraepithelial neoplasia", "risk of developing cervical cancer". The final review included 28 articles. The qualitative analysis allowed us to form an idea of the effect of AIDs on the development of intraepithelial neoplastic changes in cervical cancer (CC), in the pathogenesis of which an important place is occupied by the chronic inflammatory process – there is activation of signaling pathways, including NF-kB, JAK-STAT, MAPK and TLR. These agents induce the production of various proinflammatory, tissue-damaging factors, such as cytokines, chemokines, and metalloproteinases. In addition, both in AID and in CC, activated inflammasomes and the signaling pathway of the GMP-AMP interferon synthase stimulating gene (cGAS-STING) are involved in the development of chronic inflammation. It is noted that the C5aR system is associated with carcinogenesis activity and the recruitment of myeloid suppressor cells MDSC, which suppress the antitumor immune response. The presence of immunosuppressive therapy (mainly the use of azathioprine) plays an important role in the progression of intraepithelial changes in the cervix. Several studies present data on the positive effect of vaccination against human papillomavirus (HPV) in patients with systemic lupus erythematosus, while it is recommended to vaccinate against HPV regardless of the presence or absence of this virus in anamnesis. Along with the literature review, the article presents a clinical case of intraepithelial cervical lesion in a patient with systemic lupus erythematosus. Therefore, immunological changes in AIDs in combination with immunosuppressive therapy can contribute to the progression of carcinogenesis. At the same time, it should be noted that when studying this topic, controversial issues remain, which require further development of this problem.